The FTC made a significant policy shift in August, announcing that it will no longer pursue claims under disparate-impact or “unfair discrimination” theories. The Commission concluded it lacks statutory authority to bring such claims and that doing so would be contrary to constitutional values. This story and more after the jump.
Continue Reading FTC Updates (August 3 – August 14, 2026)
This week the Federal Trade Commission (FTC) issued warning letters to companies making allegedly questionable “Made in the USA” claims, sent more than $2.7 million in payments to workers allegedly harmed by Handy Technologies’ deceptive earnings claims, and announced a $2.25 million settlement with tenant screening company RentGrow. These consumer protection updates reflect the agency’s continued focus on advertising claims, worker-compensation disclosures, and the accuracy of consumer reporting. More on these stories after the jump.
Continue Reading FTC Blog Updates (July 6-July 10, 2026)
With summer upon us, the FTC is turning up the heat—from mortgage relief scams and healthcare merger divestitures to DEI antitrust probes and contempt proceedings against a repeat offender. All this and more after the jump.
Continue Reading FTC Blog Updates (June 1-12, 2026)
Despite only having two active Commissioners, the FTC has remained busy. The Commission resolved a long-running litigation related to sensitive consumer location data, announced a workshop on developments in the financial services industry, and approved a merger with divestiture conditions. These stories and more after the jump.
Continue Reading FTC Blog Updates (May 3 – 8, 2026)
The Federal Trade Commission (FTC) recently released its Strategic Plan for Fiscal Years 2026–2030, setting out the agency’s enforcement priorities and operational objectives for the next five years under Chairman Andrew N. Ferguson. The plan reaffirms the FTC’s commitment to vigorously enforcing the nation’s antitrust and consumer protection laws “without fear or favor.” Critically for
With the agency still operating with three Commissioner vacancies, the FTC took a range of notable actions in mid-February, spanning consumer data protection, health claims enforcement, labor market competition, and digital platform accountability. The agency’s activity to wrap February pertained primarily to rulemaking, seeking public comment about competitor collaboration, and holding a workshop about consumer data and privacy. The Commission also issued a policy statement about enforcement of the Children’s Online Privacy Protection Act, or COPPA. These stories and more after the jump.
Continue Reading FTC Updates (February 9-13, 23-27, 2026)
The FTC has been active in the consumer protection realm this week, issuing refunds and warning letters, releasing Do Not Call Registry statistics, and announcing a new workshop. The FTC also denied a petition to reopen a long-running consent order related to “stalkerware” apps. These stories and more after the jump.
Continue Reading FTC Updates (December 8 – 12, 2025)
On November 17, 2025, (former) FTC Commissioner Melissa Holyoak left the FTC to become Utah’s interim U.S. attorney. Holyoak left the FTC the same day the appointment was announced.
As a result of Holyoak’s departure, the FTC is down to two commissioners: Chairman Andrew Ferguson and Commissioner Mark Meador. With the two Republican commissioners remaining, the vacancy is unlikely to lead to any material changes at the agency.
Continue Reading FTC Down to Two Commissioners After (Former) Commissioner Holyoak Leaves for U.S. Attorney Role
On July 14, 2025, the FTC announced its enforcement action against telemedicine company NextMed over charges it used misleading prices, fake reviews and deceptive weight-loss claims to sell GLP-1 weight-loss drugs. The FTC has now settled its charges that NextMed used deceptive practices to lure consumers into buying their weight-loss membership programs that had hidden terms and conditions. With the rise of both authentic and counterfeit GLP-1s throughout the nation and the proliferation of the availability of GLP-1s from telemedicine/telehealth companies, online pharmacies and medspas, this announcement is a sign that the federal government will actively monitor these entities to ensure consumers are getting genuine, authentic GLP-1s, that consumers are making informed decisions about weight-loss drugs, and that consumers are not being deceived and duped in the frenzy over GLP-1s.
Continue Reading FTC Uses Its Consumer Protection Powers to Regulate Sellers of GLP-1s
Merger consent orders have returned to the FTC, with the agency’s latest decision highlighting how the current leadership is evaluating divestiture proposals. The FTC has approved a proposed consent agreement in Alimentation Couche-Tard Inc.’s (ACT) acquisition of retail fuel outlets from Giant Eagle, Inc. that paired standard retail divestitures with a “prior notice” requirement that